{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:43:51Z","timestamp":1788644631375,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.phymed.2023.154819","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T03:03:11Z","timestamp":1681182191000},"page":"154819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091\/hsa-miR-378g\/ARRDC3 pathway"],"prefix":"10.1016","volume":"114","author":[{"given":"Qing","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2011-4019","authenticated-orcid":false,"given":"Sumei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2023.154819_bib0001","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1158\/2159-8290.CD-20-1638","article-title":"Overcoming resistance to tumor-targeted and immune-targeted therapies","volume":"11","author":"Aldea","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2023.154819_bib0002","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1074\/jbc.RA117.001516","article-title":"The alpha-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein-coupled receptor lysosomal sorting and signaling","volume":"293","author":"Arakaki","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.phymed.2023.154819_bib0003","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.254888","article-title":"alpha-Arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis","volume":"134","author":"Arakaki","year":"2021","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.phymed.2023.154819_bib0004","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1006\/geno.1998.5276","article-title":"Structure of the human paralemmin gene (PALM), mapping to human chromosome 19p13.3 and mouse chromosome 10, and exclusion of coding mutations in grizzled, mocha, jittery, and hesitant mice","volume":"49","author":"Burwinkel","year":"1998","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.phymed.2023.154819_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-019-0943-0","article-title":"Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2023.154819_bib0006","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2023.154819_bib0007","doi-asserted-by":"crossref","first-page":"e22878","DOI":"10.1002\/jbt.22878","article-title":"LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g\/TFRC","author":"Cui","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.phymed.2023.154819_bib0008","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1038\/onc.2010.250","article-title":"ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4","volume":"29","author":"Draheim","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2023.154819_bib0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13059-014-0571-3","article-title":"CIRI: an efficient and unbiased algorithm for de novo circular RNA identification","volume":"16","author":"Gao","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.phymed.2023.154819_bib0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.phymed.2023.154819_bib0011","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2023.154819_bib0012","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2018.04.006","article-title":"Emerging landscape of circular RNAs in lung cancer","volume":"427","author":"Hu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2023.154819_bib0013","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2023.154819_bib0014","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1101\/gr.092759.109","article-title":"Circos: an information aesthetic for comparative genomics","volume":"19","author":"Krzywinski","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.phymed.2023.154819_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104946","article-title":"HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g\/HOXC13 axis","volume":"111","author":"Li","year":"2020","journal-title":"Oral Oncol."},{"key":"10.1016\/j.phymed.2023.154819_bib0016","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","article-title":"The biogenesis, functions, and challenges of circular RNAs","volume":"71","author":"Li","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2023.154819_bib0017","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2023.154819_bib0018","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","article-title":"Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis","volume":"391","author":"Moslehi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2023.154819_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/1758835921992968","article-title":"The progress and challenge of anti-PD-1\/PD-L1 immunotherapy in treating non-small cell lung cancer","volume":"13","author":"Qu","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.phymed.2023.154819_bib0020","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","article-title":"Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures","volume":"73","author":"Sanger","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phymed.2023.154819_bib0021","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1873-3468.12986","article-title":"ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAP","volume":"592","author":"Shen","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phymed.2023.154819_bib0022","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2023.154819_bib0023","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2023.154819_bib0024","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2023.154819_bib0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrg.2016.114","article-title":"Detecting circular RNAs: bioinformatic and experimental challenges","volume":"17","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.phymed.2023.154819_bib0026","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-018-0889-7","article-title":"Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-beta-induced epithelial-mesenchymal transition and metastasis by controlling TIF1gamma in non-small cell lung cancer","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2023.154819_bib0027","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2023.154819_bib0028","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1142\/S0192415X20500780","article-title":"Positive role of Chinese herbal medicine in cancer immune regulation","volume":"48","author":"Wang","year":"2020","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phymed.2023.154819_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8567905","article-title":"Decoction of Chinese Herbal Medicine Fuzheng Kang-Ai Induces Lung Cancer Cell Apoptosis via STAT3\/Bcl-2\/Caspase-3 Pathway","volume":"2018","author":"Wang","year":"2018","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.phymed.2023.154819_bib0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2019.08.016","article-title":"MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1\/CSN5 in triple-negative breast cancer","volume":"465","author":"Wang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2023.154819_bib0031","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1038\/onc.2016.147","article-title":"Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3\u2032UTR and 5\u2032UTR of Jab1\/CSN5","volume":"35","author":"Wang","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2023.154819_bib0032","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12935-020-01270-3","article-title":"Fuzheng Kang-Ai decoction enhances the effect of Gefitinib-induced cell apoptosis in lung cancer through mitochondrial pathway","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.phymed.2023.154819_bib0033","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1089\/ars.2021.0193","article-title":"The alpha-Arrestin ARRDC3 is an emerging multifunctional adaptor protein in cancer","volume":"36","author":"Wedegaertner","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phymed.2023.154819_bib0034","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S1470-2045(20)30073-5","article-title":"Cancer registration in China and its role in cancer prevention and control","volume":"21","author":"Wei","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2023.154819_bib0035","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1158\/0008-5472.CAN-19-3268","article-title":"CircFOXK2 promotes growth and metastasis of pancreatic ductal adenocarcinoma by complexing with RNA binding proteins and sponging MiR-942","volume":"80","author":"Wong","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2023.154819_bib0036","first-page":"132","article-title":"ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation","volume":"8","author":"Xiao","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.phymed.2023.154819_bib0037","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s11655-017-2819-8","article-title":"Gefitinib plus Fuzheng Kang'ai Formula (\u2007) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a randomized controlled trial","volume":"24","author":"Yang","year":"2018","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.phymed.2023.154819_bib0038","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ctim.2014.10.001","article-title":"Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study","volume":"22","author":"Yang","year":"2014","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.phymed.2023.154819_bib0039","article-title":"GPX4 plays a crucial role in Fuzheng Kang'ai decoction-induced non-small cell lung cancer cell ferroptosis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2023.154819_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12943-020-01183-9","article-title":"The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer","volume":"19","author":"Zheng","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2023.154819_bib0041","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-018-0827-8","article-title":"Circular RNAs function as ceRNAs to regulate and control human cancer progression","volume":"17","author":"Zhong","year":"2018","journal-title":"Mol. Cancer"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711323001800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711323001800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:53:20Z","timestamp":1760554400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711323001800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":41,"alternative-id":["S0944711323001800"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2023.154819","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091\/hsa-miR-378g\/ARRDC3 pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2023.154819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154819"}}